| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| The introduction of IMDELLTRA marks a critical milestone in cancer treatment, particularly for patients with extensive stage small cell lung cancer. This innovative therapy significantly reduces risks associated with traditional treatments, demonstrating promising efficacy and safety profiles. The advancements in cancer therapies not only enhance patient outcomes but also strengthen Amgen's position in the competitive oncology market. Broadly, these developments are part of a larger trend towards more targeted and personalized cancer therapies. |
| The price action of Amgen (AMGN) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for AMGN since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.9, and the negative at 0 on 2025-11-19. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Valuation Sentiment (2.7), and Sentiment towards Fundamentals (2.7) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| AMGN | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-19 | 0%(0%) | 0 | 0% | 0.9 | 2.7 | -1 | |||||||
| 2025-11-18 | 0%(0%) | 0 | 0% | 1.3 | 1.7 | -1 | |||||||
| 2025-11-17 | 0%(0%) | 0 | 0% | 1.1 | 2.3 | -1 | |||||||
| 2025-11-16 | 0%(0%) | 0 | 0% | 1 | 3.4 | -1 | |||||||
| 2025-11-15 | 0%(0%) | 0 | 0% | 1 | 3.4 | -1 | |||||||
| 2025-11-14 | 0%(0%) | 0 | 0% | 1.4 | 3.7 | -1 | |||||||
| 2025-11-13 | 0%(0%) | 0 | 0% | 1.3 | 3.7 | -1 | |||||||
| 2025-11-12 | 0%(0%) | 0 | 0% | 1.1 | 3.2 | -1 | |||||||
| 2025-11-11 | 0%(0%) | 0 | 0% | 0.8 | 3.7 | -1 | |||||||
| 2025-11-10 | 0%(0%) | 0 | 0% | 0.7 | 3.4 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-19 17:07:07 The full approval of a novel treatment provides Amgen with a competitive advantage in the oncology market, potentially increasing its market share. |
| 2025-11-19 17:07:07 Amgen’s successful approval of IMDELLTRA enhances its reputation in the biotech industry as a leader in innovative cancer therapies. |
| 2025-11-19 17:07:07 The recognition of IMDELLTRA as a standard of care indicates a shift toward more standardized treatment protocols in oncology. |
| 2025-11-19 17:07:07 The introduction of IMDELLTRA represents a significant advancement in the treatment of extensive stage small cell lung cancer, reducing risks associated with previous therapies. |
| 2025-11-19 17:07:07 The FDA's full approval of IMDELLTRA highlights the importance of regulatory bodies in the validation and acceptance of innovative cancer treatments. |